(no title)
v4dok
|
2 years ago
I think value-based care is the only real incentive on this. Otherwise, there is simply no reason for anyone to care enough. Even the insurers, they found a way to make money by making sure their premiums factor in these things. In the expense of the patient. As long as the drug doesn't kill people, who cares if it works if I make money off it as a pharma? Unfortunately, value-based care can only be pushed top-down. Patients are not in a position of power against pharma companies on this matter.
No comments yet.